Adding to the complexity is the finding that, in the great majority of pancreatic tumors, neither the number of single nucleotide variants nor neoantigen number were associated with CD8+ T cell infiltration or other markers of anti-tumor immunity. The gene discussed is CD8A; the disease is neoplasm.